Esophageal dilation is the mechanical stretching of a narrowed segment of the esophagus to restore a lumen wide enough for normal swallowing (Sethi and Richter, The Esophagus, 2021). It is the cornerstone treatment for benign esophageal strictures — the most common of which are peptic (reflux) strictures and Schatzki rings, both rooted in gastroesophageal reflux disease (see our Esophageal Stricture and GERD / Acid Reflux pages) (Sethi and Richter, The Esophagus, 2021). Dilation is performed with one of two broad techniques: mechanical (push-type) dilators such as weighted Maloney bougies or wire-guided Savary-Gilliard polyvinyl dilators, which the surgeon passes across the narrowing, and balloon dilators, which are positioned across the stricture and inflated to deliver radial force (Coronel and Waxman, Yamada's Textbook of Gastroenterology, 2022; McCain et al., Cochrane Database of Systematic Reviews, 2016).

The goal of dilation is practical: restore a lumen that lets the patient eat a solid diet, generally a diameter of about 15–18 mm (Sethi and Richter, The Esophagus, 2021). Benign strictures are categorized as simple (short, straight, focal — peptic strictures, Schatzki rings, webs) or complex (long, angulated, tightly narrowed, or those from caustic injury, radiation, surgical anastomoses, or eosinophilic esophagitis); simple strictures respond well, with 95% of patients improving within five or fewer sessions, while complex strictures require more sessions and recur more often (Sethi and Richter, The Esophagus, 2021). Beyond fixed strictures, graded dilation and large-diameter pneumatic dilation are also used to treat the functional obstruction of achalasia and selected cases of esophagogastric junction outflow obstruction (EGJOO) by forcibly disrupting the lower esophageal sphincter (Patel et al., Gastroenterology, 2022). The overall need for stricture dilation has declined with the widespread use of proton pump inhibitors (PPIs), which limit the reflux injury that creates peptic strictures in the first place (Coronel and Waxman, Yamada's Textbook of Gastroenterology, 2022).

‍

An esophageal stricture narrows the lumen because repeated injury — most often from acid reflux — deposits fibrous scar tissue that contracts over time, mechanically obstructing the passage of food (Sethi and Richter, The Esophagus, 2021). Dilation applies controlled radial and longitudinal force to that scarred segment, stretching and partially fracturing the fibrotic tissue to widen the channel (Coronel and Waxman, Yamada's Textbook of Gastroenterology, 2022). With a bougie, a tapered dilator is advanced across the stricture, delivering a combination of radial and longitudinal (shearing) force; a key advantage is that the endoscopist can "feel" the resistance and limit the diameter accordingly (Singh et al., Surgical Endoscopy, 2023). With a balloon, the device is positioned across the narrowing and inflated to a set diameter, delivering purely radial force (McCain et al., Cochrane Database of Systematic Reviews, 2016).

For most simple strictures the two techniques are equally effective and equally safe, as confirmed by randomized trials and meta-analysis (ASGE Standards of Practice Committee, 2012; McCain et al., Cochrane Database of Systematic Reviews, 2016). Because stretching alone does not address the cause, the durability of the result depends on controlling the underlying driver — which for peptic strictures and reflux-related Schatzki rings means continuous acid suppression to prevent the scar from reforming, and for eosinophilic esophagitis means anti-inflammatory therapy, since dilation relieves the narrowing but does not treat the underlying mucosal disease (Sethi and Richter, The Esophagus, 2021; Muir and Falk, JAMA, 2021).

• High rate of swallowing relief — endoscopic dilation relieves dysphagia in roughly 70%–90% of patients with benign strictures, and most simple strictures improve within one to three sessions (Sethi and Richter, The Esophagus, 2021).

• Minimally invasive and outpatient — performed endoscopically without incisions, usually under sedation as a same-day procedure, with rapid return to normal activity (Coronel and Waxman, Yamada's Textbook of Gastroenterology, 2022).

• Restores a normal diet — dilating to about 15–18 mm allows most patients to tolerate solid food again (Sethi and Richter, The Esophagus, 2021).

• Excellent safety profile — serious complications are uncommon, with perforation rates of approximately 0.1%–0.6% for benign strictures in experienced hands (Fugazza and Repici, Dysphagia, 2021).

• Highly effective across causes — including Schatzki rings (a single large-bougie passage relieves symptoms in nearly all patients), eosinophilic esophagitis (clinical improvement in 95%), and achalasia/EGJOO via pneumatic dilation (Pasha et al., ASGE Guideline, 2014; Muir and Falk, JAMA, 2021; Patel et al., Gastroenterology, 2022).

• Diagnostic and therapeutic in one session — dilation is typically performed at endoscopy, allowing simultaneous visualization, biopsy to exclude malignancy or eosinophilic esophagitis, and treatment (Sethi and Richter, The Esophagus, 2021).

‍

Candidacy depends on the type and cause of narrowing and the presence of dysphagia (Sethi and Richter, The Esophagus, 2021). Appropriate candidates include:

• Symptomatic benign strictures — peptic (reflux) strictures, Schatzki rings, and esophageal webs causing solid-food dysphagia (see our Esophageal Stricture page) (Sethi and Richter, The Esophagus, 2021).

• Complex benign strictures — anastomotic, caustic, radiation-induced, post-endoscopic, and medication-induced narrowings, which require more sessions and careful, often fluoroscopy-guided, technique (Fugazza and Repici, Dysphagia, 2021).

• Eosinophilic esophagitis with stricture or narrow-caliber esophagus causing dysphagia or food impaction, ideally combined with anti-inflammatory therapy (Dellon et al., ACG Clinical Guideline, 2025).

• Achalasia and selected EGJOO — appropriate candidates for graded pneumatic dilation as an alternative to myotomy, particularly older patients and those preferring a non-surgical option (see our Achalasia and EGJOO pages) (Patel et al., Gastroenterology, 2022).

• Food bolus impaction related to an underlying ring or stricture, often dilated after the impaction is cleared (Sethi and Richter, The Esophagus, 2021).

Dilation should be approached cautiously or deferred when a malignant stricture is suspected until tissue diagnosis and staging are complete, and in patients who cannot safely undergo endoscopy or sedation; higher-risk settings (caustic, radiation, very tight, or angulated strictures) call for an experienced operator and often fluoroscopic guidance (ASGE Standards of Practice Committee, 2012; Coelho-Prabhu et al., ASGE Guideline, 2022).

‍

Esophageal dilation is performed at upper endoscopy, typically under moderate sedation or monitored anesthesia, as an outpatient procedure (Coronel and Waxman, Yamada's Textbook of Gastroenterology, 2022). After the endoscope inspects the esophagus and localizes the narrowing — with biopsies taken as needed to exclude malignancy or eosinophilic esophagitis — the surgeon selects a technique based on the stricture's characteristics (Sethi and Richter, The Esophagus, 2021).

For wire-guided bougie dilation, a guidewire with a soft spring tip is passed endoscopically across the stricture (position confirmed by fluoroscopy when needed); the endoscope is withdrawn, and thermoplastic Savary-Gilliard dilators of progressively larger diameter are passed over the wire across the narrowing (Coronel and Waxman, Yamada's Textbook of Gastroenterology, 2022). For through-the-scope (TTS) balloon dilation, a controlled radial expansion (CRE) balloon — available from 4 to 20 mm — is passed through the endoscope, positioned across the stricture under direct vision, and inflated to a graduated target diameter measured in atmospheres of pressure (Coronel and Waxman, Yamada's Textbook of Gastroenterology, 2022). A complex stricture is dilated over a guidewire, often with fluoroscopy (Coronel and Waxman, Yamada's Textbook of Gastroenterology, 2022). A Schatzki ring is often treated effectively with a single passage of a large (16–20 mm) bougie to fracture the ring (Pasha et al., ASGE Guideline, 2014).

The "rule of 3s" — passing no more than three progressively larger dilators once moderate resistance is met — has long been a safety convention to avoid over-dilation, though recent large series show that non-adherence does not clearly increase complications; excessive resistance is nonetheless avoided to reduce perforation and bleeding risk (Coronel and Waxman, Yamada's Textbook of Gastroenterology, 2022; Fugazza and Repici, Dysphagia, 2021). For achalasia, graded pneumatic dilation uses a large (30-, 35-, or 40-mm) non-compliant balloon positioned across the lower esophageal sphincter and inflated to forcibly disrupt the muscle fibers, typically starting at 30 mm with staged escalation (Patel et al., Gastroenterology, 2022). After dilation, the segment is re-inspected endoscopically to assess the result and exclude a mucosal tear or perforation (Patel et al., Gastroenterology, 2022).

‍

Esophageal dilation is safe in experienced hands, but patients are counseled candidly about its risks (Sethi and Richter, The Esophagus, 2021):

• Perforation — the most feared complication, occurring in approximately 0.1%–0.6% of benign stricture dilations; a nationwide study of over 160,000 dilations reported a rate of 0.09% (Fugazza and Repici, Dysphagia, 2021; Coelho-Prabhu et al., ASGE Guideline, 2022). Risk is higher for complex, caustic (reported 5.6%–36.4%), radiation, and malignant strictures, and with blind (non-wire-guided) passage of dilators in complex strictures (ASGE Standards of Practice Committee, 2012; Coelho-Prabhu et al., ASGE Guideline, 2022).

• Pneumatic dilation for achalasia carries a higher perforation risk of about 1%–3%, greater at the initial session and with larger (35-mm vs 30-mm) balloons (Patel et al., Gastroenterology, 2022; Coelho-Prabhu et al., ASGE Guideline, 2022).

• Bleeding — significant bleeding occurs in fewer than 0.5% of dilations (Fugazza and Repici, Dysphagia, 2021).

• Bacteremia — transient bacteremia is relatively common (up to ~23%) but rarely clinically significant (Fugazza and Repici, Dysphagia, 2021).

• Chest discomfort — the most frequent minor event, especially in eosinophilic esophagitis, reported in roughly 24% of patients, usually self-limited (Muir and Falk, JAMA, 2021).

• Operator- and lesion-related risk factors — male sex, age ≥70, smaller initial stricture diameter (<10 mm), distal location, caustic/radiation etiology, and lower operator experience; perforation risk was 4-fold higher among operators who had performed fewer than 500 prior endoscopies (Sethi and Richter, The Esophagus, 2021; Coelho-Prabhu et al., ASGE Guideline, 2022).

• Need for repeat procedures — recurrence is common, and up to 40% of patients require more than three sessions (particularly complex strictures) (Fugazza and Repici, Dysphagia, 2021).

Warning signs of perforation — severe or persistent chest pain, shortness of breath, rapid heart rate, fever, or neck/chest crepitus — require immediate evaluation with a water-soluble contrast study; most perforations are managed non-operatively with antibiotics and, when needed, a covered stent (Sethi and Richter, The Esophagus, 2021).

‍

Recovery from esophageal dilation is typically rapid (Coronel and Waxman, Yamada's Textbook of Gastroenterology, 2022). After the sedation wears off, most patients are observed briefly, monitored for any signs of perforation (chest pain, fever, shortness of breath), and discharged the same day. Mild throat discomfort or transient chest soreness is common and usually resolves within a day or two. Patients generally resume clear liquids once fully awake and advance to a soft diet and then solids over the next day or two, depending on how much the esophagus was dilated and the underlying condition. Eating slowly, chewing thoroughly, and staying well hydrated ease the transition. There is no routine need for a post-procedure contrast study unless perforation is clinically suspected (Patel et al., Gastroenterology, 2022). Because dilation treats the narrowing but not its cause, patients with reflux-related strictures continue — or begin — acid-suppressing medication immediately to protect the result (Maret-Ouda et al., JAMA, 2020).

‍

The long-term outlook is excellent for simple benign strictures and governed by one principle: dilation reopens the esophagus, but durable control of the underlying cause keeps it open (Sethi and Richter, The Esophagus, 2021). Simple peptic strictures and Schatzki rings respond well, and more than 60% of patients remain free of any further dilation after the first year when the underlying reflux is treated (Vermeulen et al., Gastrointestinal Endoscopy, 2020). For reflux-related strictures, consistent PPI therapy dramatically lowers recurrence — after a Schatzki ring is dilated, maintenance PPI reduced recurrent dysphagia to about 7% versus 47% without it (Khalaf and Castell, The Esophagus, 2021). Complex strictures (caustic, radiation, anastomotic, eosinophilic) require more sessions and recur more often; a minority become refractory (unable to reach 14 mm over five sessions) or recurrent, calling for adjunctive therapies (Daoud et al., Digestive Diseases and Sciences, 2022). Some patients with chronic strictures enter a planned program of periodic maintenance dilation. For achalasia treated with pneumatic dilation, long-term success is roughly 90% at 6 months declining to about 44% at 6 years, so repeat dilations over the years are anticipated (Patel et al., Gastroenterology, 2022).

‍

An esophageal stricture is rarely a stand-alone problem — it is most often the scarred signature of reflux disease, which is why dilation delivers its best and most lasting results when performed by a foregut specialist who treats the entire esophagus rather than the narrowing in isolation. Dr. Nestor de la Cruz-Muñoz, MD, FACS, DABOM, is a board-certified minimally invasive foregut and bariatric surgeon in Miami whose practice encompasses the full spectrum of esophageal narrowing — from simple peptic strictures and Schatzki rings to complex and refractory strictures, eosinophilic esophagitis, and the functional obstruction of achalasia and EGJOO. Every patient is evaluated not only for the dilation they need now, but for the underlying driver — the degree of acid reflux, a coexisting hiatal hernia, Barrett's esophagus, a motility disorder, or eosinophilic inflammation — so the plan pairs expert dilation with definitive treatment of the cause (see our GERD / Acid Reflux, Hiatal & Paraesophageal Hernia, Achalasia, and Antireflux Surgery pages). That means malignancy is always excluded before a narrowing is called benign, reflux-driven strictures are protected with durable acid control or, when appropriate, definitive antireflux surgery rather than an endless cycle of dilations, and achalasia is dilated or myotomized based on objective testing. Outcomes in dilation are tied directly to operator experience, and that whole-esophagus expertise — knowing not just how to dilate, but what the narrowing truly represents and how to keep it from coming back — is what makes this practice a trusted destination across South Florida for difficult swallowing.

‍

Expected Dysphagia Relief & Symptom Outcomes

Esophageal dilation is intended to restore comfortable swallowing, and relief of dysphagia is the primary measure of success (Sethi and Richter, The Esophagus, 2021). Expected outcomes include prompt relief of solid-food dysphagia in roughly 70%–90% of patients with benign strictures, with most simple strictures controlled in one to three sessions and the ability to eat a normal solid diet restored once the lumen reaches about 15–18 mm (Sethi and Richter, The Esophagus, 2021; Daoud et al., Digestive Diseases and Sciences, 2022). For eosinophilic esophagitis, dilation yields clinical improvement in about 95% of patients, and for a Schatzki ring a single large dilation relieves symptoms in nearly all (Muir and Falk, JAMA, 2021; Pasha et al., ASGE Guideline, 2014). Patients are counseled that symptoms can recur and that repeat dilation is sometimes needed, with durability driven by treatment of the underlying cause (Vermeulen et al., Gastrointestinal Endoscopy, 2020).

‍

Expected Swallowing & Functional Outcomes

The measurable goal is a restored esophageal lumen that passes a solid bolus, not metabolic change (Sethi and Richter, The Esophagus, 2021). Dilating to a larger final diameter (16–18 mm) is associated with fewer subsequent sessions than stopping at 13–15 mm, so the target diameter is matched to the stricture and the patient's tolerance (Vermeulen et al., Gastrointestinal Endoscopy, 2020). For functional obstruction at the esophagogastric junction, graded pneumatic dilation restores emptying by disrupting the lower esophageal sphincter, with outcomes that are durable in many patients but may require repeat dilation over the years, and that are compared individually against myotomy (Heller or POEM) based on achalasia subtype, age, and preference (see our Achalasia and Heller Myotomy pages) (Patel et al., Gastroenterology, 2022).

‍

Stricture Recurrence Prevention Strategy

Because recurrence is the principal long-term challenge, prevention is built into the treatment plan (Sethi and Richter, The Esophagus, 2021). The cornerstone for the common reflux-related strictures is lifelong acid suppression, which markedly reduces recurrent narrowing and recurrent dysphagia after dilation (Khalaf and Castell, The Esophagus, 2021; Maret-Ouda et al., JAMA, 2020). For eosinophilic esophagitis, dilation is paired with anti-inflammatory therapy (topical steroids, dietary therapy, or biologics), since histologic control reduces the need for subsequent dilation (Dellon et al., ACG Clinical Guideline, 2025). For refractory or recurrent strictures, adjuncts include intralesional corticosteroid injection, needle-knife incisional therapy, mitomycin C, self-dilation programs, and temporary stenting (Daoud et al., Digestive Diseases and Sciences, 2022). When a peptic stricture reflects severe, objectively confirmed reflux — especially with a significant hiatal hernia — definitive antireflux surgery after adequate dilation can break the cycle of recurrence better than indefinite medical therapy plus periodic dilation (see our Antireflux Surgery and Hiatal & Paraesophageal Hernia pages) (Maret-Ouda et al., JAMA, 2020).

‍

Reflux is the central consideration in esophageal dilation because the majority of benign strictures and most Schatzki rings are complications of GERD (Sethi and Richter, The Esophagus, 2021). A peptic stricture is, by definition, proof of longstanding, significant acid exposure, which is why these patients also warrant evaluation for the other points on the GERD continuum — erosive esophagitis and Barrett's esophagus — and continuous acid suppression is integral to keeping the dilated segment open (see our Erosive Esophagitis, Barrett's Esophagus, and GERD / Acid Reflux pages) (Khalaf and Castell, The Esophagus, 2021; Maret-Ouda et al., JAMA, 2020). Importantly, in eosinophilic esophagitis and peptic strictures, dilation is typically postponed to allow mucosal healing with medical therapy where feasible, since controlling inflammation can itself increase esophageal caliber and reduce the need for or extent of dilation (Hirano and Furuta, Gastroenterology, 2020; Muir and Falk, JAMA, 2021). Patients with reflux-driven strictures are counseled that the dilation addresses the mechanical narrowing while the acid control addresses the cause.

‍

Recurrent dysphagia or an inadequately dilated stricture is managed in a stepwise, individualized fashion (Daoud et al., Digestive Diseases and Sciences, 2022). Most patients are managed with repeat dilation, often to a larger final diameter, combined with optimization of acid suppression or anti-inflammatory therapy (Vermeulen et al., Gastrointestinal Endoscopy, 2020). For strictures that prove refractory or recurrent, the escalation ladder includes intralesional steroid injection, endoscopic incisional (needle-knife) therapy — particularly effective for refractory Schatzki rings — mitomycin C application, supervised self-dilation, and temporary placement of a removable esophageal stent (Daoud et al., Digestive Diseases and Sciences, 2022; Khalaf and Castell, The Esophagus, 2021). Surgery is reserved as a last resort for the small minority of truly refractory benign strictures (Fugazza and Repici, Dysphagia, 2021). For reflux-driven strictures that keep recurring, definitive antireflux surgery is an important revision pathway after adequate dilation (see our Antireflux Surgery and Nissen Fundoplication pages) (Maret-Ouda et al., JAMA, 2020).

‍

Rather than reducing body mass, the priority after esophageal dilation is restoring normal, comfortable eating and rebuilding any nutritional reserve lost to pre-procedure dysphagia (Sethi and Richter, The Esophagus, 2021). Patients with high-grade strictures often eat poorly beforehand because food sticks, and some lose weight or adopt restrictive, soft-food diets; dilation is designed to let them resume a full, balanced diet (Sethi and Richter, The Esophagus, 2021). As the lumen is restored, patients advance from liquids to soft foods to solids, eating slowly and chewing thoroughly, with attention to adequate protein and caloric intake. Any significant unintentional weight loss before treatment is a red flag that prompts exclusion of malignancy before a narrowing is assumed benign (see our Esophageal Stricture and Esophageal Adenocarcinoma pages) (Sethi and Richter, The Esophagus, 2021).

‍

Esophageal dilation is covered as a medically necessary treatment for a documented esophageal narrowing causing dysphagia, in contrast to elective procedures. Payers typically expect documentation establishing the diagnosis and indication — endoscopic and/or radiographic demonstration of a stricture, ring, web, or motility-related obstruction, with biopsy to characterize the cause and exclude malignancy where relevant (Sethi and Richter, The Esophagus, 2021; Pasha et al., ASGE Guideline, 2014). Specific coverage, documentation, coding, and any pre-authorization requirements should be confirmed with each individual plan.

‍

• Upper endoscopy and/or barium esophagram to confirm and characterize the narrowing; a barium tablet or marshmallow bolus is especially useful for Schatzki rings, which can be missed endoscopically (Pasha et al., ASGE Guideline, 2014; Sethi and Richter, The Esophagus, 2021).

• Biopsies to exclude malignancy and eosinophilic esophagitis when clinically indicated (Dellon et al., ACG Clinical Guideline, 2025).

• High-resolution manometry when a motility disorder such as achalasia or EGJOO is suspected, particularly if a presumed stricture responds poorly to dilation (see our Achalasia and EGJOO pages) (Patel et al., Gastroenterology, 2022).

• Fasting before the procedure per endoscopy/sedation protocols, and review of anticoagulant and antiplatelet medications (Coelho-Prabhu et al., ASGE Guideline, 2022).

• Optimization of the underlying cause — initiation or continuation of PPI therapy for reflux strictures, or anti-inflammatory therapy for eosinophilic esophagitis, to improve durability (Maret-Ouda et al., JAMA, 2020; Muir and Falk, JAMA, 2021).

‍

‍

Oral intake usually resumes with clear liquids once the patient is fully awake from sedation, advancing to soft foods and then solids over the following day or two as tolerated, depending on the degree of dilation and the underlying condition (Coronel and Waxman, Yamada's Textbook of Gastroenterology, 2022). Patients are advised to eat small amounts slowly, chew thoroughly, stay upright during and after meals, and remain well hydrated. For reflux-related strictures, continuing acid-suppressing medication is emphasized from the outset to protect the result. Any severe chest pain, fever, or difficulty breathing after the procedure should prompt immediate contact, as these can signal perforation (Sethi and Richter, The Esophagus, 2021).

‍

Because esophageal dilation is a minimally invasive endoscopic procedure, most patients return to normal activity the day after the procedure once the effects of sedation have fully worn off (Coronel and Waxman, Yamada's Textbook of Gastroenterology, 2022). Patients should not drive or make important decisions on the day of the procedure due to sedation. There are no incisions and no specific lifting restriction from the dilation itself; patients are simply monitored for warning signs of perforation in the first 24 hours and advised to seek care urgently for severe chest pain, shortness of breath, or fever (Sethi and Richter, The Esophagus, 2021).